Osaic Holdings
HTGM

Osaic Holdings’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Osaic Holdings’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 7696
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7776
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7737
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7721
2021
Q3 		$0 Sell
1
-1
-50% -$72 ﹤0.01% 7429
2021
Q2 		$0 Hold
2
– – ﹤0.01% 7224
2021
Q1 		$0 Hold
2
– – ﹤0.01% 7032
2020
Q4 		$0 Sell
2
-1
-33% -$58 ﹤0.01% 6688
2020
Q3 		$0 Sell
3
-1
-25% -$89 ﹤0.01% 6514
2020
Q2 		$0 Sell
4
-2
-33% -$177 ﹤0.01% 6432
2020
Q1 		$0 Buy
+6
New +$587 ﹤0.01% 6258

Other funds holding HTGM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's HTGM Position: Q3 2022 in Review

Osaic Holdings sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2022, closing a stake of 1 share.

Osaic Holdings first reported a position in HTGM in Q1 2020 and held it in 10 quarters. The position peaked at $0 in Q2 2022. 18 funds tracked by Wall St. Rank hold HTGM as of Q3 2022.

  • Osaic Holdings reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Osaic Holdings sold 1 HTG Molecular Diagnostics, Inc. Common Stock share in Q3 2022.
  • Osaic Holdings first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Osaic Holdings's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $0 in Q2 2022.
  • 18 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.